Li, PavliΔ, Ibrahim, Wu and Shapiro (bioRxiv, Nov 2025) propose genetically encoded oxidative modulation: the photosensitizer miniSOG is illuminated at 470 nm to produce ROS in situ, which oxidatively shifts the behavior of co-expressed target proteins. Three observations support this: (1) HyPerRed fluorescence rises in miniSOG-expressing HEK293T cells during 60 s blue-light exposure, graded at 17 and 33 mW cmβ»Β² and absent at 0 mW cmβ»Β² ; (2) TRPV1 and TRPA1 β channels with established redox/cysteine sensitivity β but not TRPV4, generate jRGECO1a-reported CaΒ²βΊ influx during illumination; TRPA1 shows the largest amplitude and fastest onset ; (3) activation scales with light duration (1β60 s) and plasmid ratio, and LCK-anchored membrane miniSOG outperforms cytosolic miniSOG . The miniSOG-alone control (no channel β no CaΒ²βΊ signal) supports channel-dependence of the readout.
miniSOG itself is well established β originally as a correlated light/electron microscopy tag β and its destructive/labeling uses (CALI, proximity labeling) are mature. The reframing of ROS as a reversible regulatory signal rather than a destructive one is the conceptual novelty. However, the oxidative gating of TRP channels by exogenous ROS is already documented (e.g., lipid-oxidation-mediated ferritin-tagged channel activation ); the advance is the genetic encodability and tunability of the oxidant source, not the target chemistry.
Confidence note: the core observation (lightβminiSOGβROSβredox protein modulation) is chemically plausible and internally consistent across four independent experiment families, but the evidence base (HEK293T, n=3, no scavenger rescue) is pre-print-stage. The strongest conclusion is the tunability/localization design principle; the weakest is generality to βdiverse proteins.β What would falsify or revise it: scavenger rescue failure, a non-ROS-generating miniSOG mutant still activating TRPA1, or response failure in primary/non-HEK cells.
A credible, well-controlled-within-limits proof-of-concept that reframes genetically encoded ROS generation from a destructive/labeling tool into a tunable regulatory modality. Its principal value is the parameter-space map (intensity, duration, ratio, localization) and the membrane-anchoring design principle. Its principal weaknesses are small n, missing pharmacologic/mechanistic controls, absence of reversibility quantification, and no data outside HEK293T. Peer review should demand: ROS-scavenger and mutant-photosensitizer controls, direct oxidation-state readouts, phototoxicity/viability assays, and at least one second cell type.
Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.